This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goto, A. Articles by Omata, M. Search for Related Content PubMed PubMed Citation Articles by Goto, A. Articles by Omata, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB OUABAIN

(Hypertension. 1996;28:421-425.)
© 1996 American Heart Association, Inc.

Articles

Ouabainlike Compound in Hypertension Associated With Ectopic Corticotropin Syndrome

Atsuo Goto; Kaoru Yamada; Hisanori Hazama; Yoshio Uehara; Keiichiro Atarashi; Yasunobu Hirata; Kenjiro Kimura; Masao Omata

the Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, and Department of Human Dry Dock, Sanraku Hospital (K.Y.), Tokyo, Japan.

Molecular mechanisms related to sodium retention have been implicated in the pathogenesis of hypertension. It is unclear how sodium retention leads to a rise in blood pressure, but ouabainlike compound may act as a final common pathway in sodium-induced hypertension. In ectopic corticotropin syndrome, hypertension has been attributed to cortisol inactivation overload, giving rise to mineralocorticoid-type hypertension. We sequentially measured plasma and urinary levels of ouabainlike compound over 2 months to evaluate its role in the hypertensive mechanisms in a 64-year-old man with this syndrome caused by lung cancer. His data included hypokalemia and increased cortisol concentrations, corticotropin levels, and urinary 17-hydroxycorticosteroid excretion. Plasma renin activity was suppressed. Plasma and urinary levels of ouabainlike compound were markedly increased concomitantly with high blood pressure. The maximum plasma level was 40-fold the normal range of the subject. After chemotherapy, ouabainlike compound levels gradually decreased in parallel with the decline in blood pressure and rise in potassium concentration. A correlation was observed between plasma and urinary levels of ouabainlike compound (P<.05). Plasma and urinary levels of ouabainlike compound correlated with systolic (P<.01) and diastolic (P<.05) pressures, respectively. The peak of ouabainlike compound in plasma and urine coincided with that of authentic ouabain on high-performance liquid chromatography. Ouabainlike compound derived from urine inhibited [³H]ouabain binding to human erythrocytes. These findings suggest that ouabainlike compound with biological activity could partly account for hypertension in ectopic corticotropin syndrome.

Key Words: hormones • adrenocorticotropic hormone • Na⁺,K⁺-transporting ATPase • sodium-potassium pump • blood pressure • potassium • sodium

This article has been cited by other articles:

				K. Ihenetu, H. M. Qazzaz, F. Crespo, R. Fernandez-Botran, and R. Valdes Jr Digoxin-Like Immunoreactive Factors Induce Apoptosis in Human Acute T-Cell Lymphoblastic Leukemia Clin. Chem., July 1, 2007; 53(7): 1315 - 1322. [Abstract] [Full Text] [PDF]

				M. P. Blaustein, J. Zhang, L. Chen, and B. P. Hamilton How does salt retention raise blood pressure? Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R514 - R523. [Abstract] [Full Text] [PDF]

				I. Dostanic-Larson, J. N. Lorenz, J. W. Van Huysse, J. C. Neumann, A. E. Moseley, and J. B Lingrel Physiological role of the {alpha}1- and {alpha}2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R524 - R528. [Abstract] [Full Text] [PDF]

				J. H. Kaplan The sodium pump and hypertension: A physiological role for the cardiac glycoside binding site of the Na,K-ATPase PNAS, November 1, 2005; 102(44): 15723 - 15724. [Full Text] [PDF]

				I. Dostanic-Larson, J. W. Van Huysse, J. N. Lorenz, and J. B Lingrel From The Cover: The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation PNAS, November 1, 2005; 102(44): 15845 - 15850. [Abstract] [Full Text] [PDF]

				J. R. Shah, J. Laredo, B. P. Hamilton, and J. M. Hamlyn Different Signaling Pathways Mediate Stimulated Secretions Of Endogenous Ouabain and Aldosterone From Bovine Adrenocortical Cells Hypertension, January 1, 1998; 31(1): 463 - 468. [Abstract] [Full Text] [PDF]

				M. Ferrandi, P. Manunta, S. Balzan, J. M. Hamlyn, G. Bianchi, and P. Ferrari Ouabain-like Factor Quantification in Mammalian Tissues and Plasma : Comparison of Two Independent Assays Hypertension, October 1, 1997; 30(4): 886 - 896. [Abstract] [Full Text]